{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:06:48Z","timestamp":1791421608987,"version":"4.3.3"},"reference-count":79,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"DOI":"10.1590\/0037-8682-0552-2022","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T12:39:37Z","timestamp":1684759177000},"source":"Crossref","is-referenced-by-count":6,"title":["Clinical outcomes of intravitreal treatment for ocular toxoplasmosis: systematic review and meta-analysis"],"prefix":"10.1590","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-1602","authenticated-orcid":false,"given":"Lutiana Amaral de","family":"Melo","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Ezequiel Dias,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-7904","authenticated-orcid":false,"given":"Mayara Rodrigues Brand\u00e3o de","family":"Paiva","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Ezequiel Dias,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9934-5310","authenticated-orcid":false,"given":"Gabriella Maria","family":"Fernandes-Cunha","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine,  United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-8936","authenticated-orcid":false,"given":"Armando","family":"Silva-Cunha","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-3579","authenticated-orcid":false,"given":"Marcos Paulo Gomes","family":"Mol","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Ezequiel Dias,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-5211","authenticated-orcid":false,"given":"S\u00edlvia Ligorio","family":"Fialho","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Ezequiel Dias,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux F","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpara.2013.09.007","article-title":"New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis","volume":"44","author":"Pfaff AW","year":"2014","journal-title":"Int J Parasitol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ajo.2008.06.027","article-title":"Respective Roles of Acquired and Congenital Infections in Presumed Ocular Toxoplasmosis","volume":"146","author":"Delair E","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09273948.2011.564068","article-title":"Clinical manifestations of ocular toxoplasmosis","volume":"19","author":"Delair E","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"100882","DOI":"10.1016\/j.preteyeres.2020.100882","article-title":"Pathogenesis of ocular toxoplasmosis","volume":"81","author":"Smith JR","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"ref6","first-page":"CD007417","article-title":"Corticosteroids as adjuvant therapy for ocular toxoplasmosis","volume":"1","author":"Jasper S","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00436-018-5950-3","article-title":"Investigation of tissue cysts in the retina in a mouse model of ocular toxoplasmosis: distribution and interaction with glial cells","volume":"117","author":"Song HB","year":"2018","journal-title":"Parasitol Res"},{"issue":"2-3","key":"ref8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpara.2020.11.001","article-title":"Control of human toxoplasmosis","volume":"51","author":"Smith NC","year":"2021","journal-title":"Int J Parasitol"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.oftal.2019.09.005","article-title":"Intravitreal clindamycin as a therapeutic alternative in severe ocular toxoplasmosis","volume":"94","author":"Tabuenca Del Barrio L","year":"2019","journal-title":"Arch Soc Esp Oftalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.2147\/OPTH.S288725","article-title":"Intravitreal clindamycin as first-line therapy for toxoplasmic retinochoroiditis: A case series","volume":"14","author":"Verma L","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"101093","DOI":"10.1016\/j.ajoc.2021.101093","article-title":"Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis","volume":"22","author":"Jorge R","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher D","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"ref13","first-page":"1","article-title":"Prevalence of incidence of a health problem","volume":"30","author":"Loney PL","year":"1998","journal-title":"Chronic Dis Can"},{"key":"ref14","series-title":"Summing Up: The science of Reviewing Research","author":"Light RJ","year":"1984"},{"key":"ref15","first-page":"36","article-title":"Conducting Meta-Analyses in R with the metafor Package","author":"Viechtbauer W","year":"2010","journal-title":"J Stat Softw"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archopht.126.8.1152","article-title":"Toxoplasmosis-Associated Neovascular Lesions Treated Successfully with Ranibizumab and Antiparasitic Therapy","volume":"126","author":"Benevento JD","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.oftal.2011.09.005","article-title":"Macular toxoplasmosis and intravitreal clindamycin: an altenative to oral treatment","volume":"87","author":"Martinez-Castillo S","year":"2012","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40942-020-00225-0","article-title":"Toxoplasmosis chorioretinitis mimicking acute retinal necrosis associated with local corticosteroid","volume":"6","author":"Crosson JN","year":"2020","journal-title":"Int J Retin Vitr"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.oftal.2010.10.007","article-title":"Toxoplasmic retinochoroiditis: relapse vs choroidal neovascular membrane","volume":"85","author":"Cordero-Coma M","year":"2010","journal-title":"Arch la Soc Espa\u00f1ola Oftalmol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3928\/23258160-20150101-27","article-title":"The role of intravitreal trimethoprim\/sulfamethoxazole in the treatment of toxoplasma retinochoroiditis","volume":"46","author":"Choudhury H","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ICB.0b013e3181ff09ae","article-title":"Successful Treatment of Toxoplasmosis-Associated Choroidal Neovascular Lesions With Bevacizumab and Antiparasitic Therapy","volume":"5","author":"Lin C","year":"2011","journal-title":"Retin Cases Brief Rep"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QCO.0000000000000577","article-title":"Approach to ocular toxoplasmosis including pregnant women","volume":"32","author":"Cort\u00e9s JA","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"ref23","first-page":"391","article-title":"Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization","volume":"9","author":"Petrou P","year":"2013","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","article-title":"Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis","volume":"118","author":"Soheilian M","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"ref25","first-page":"312","article-title":"Manejo de Toxoplasmosis Ocular Severa con Clindamicina y Triamcinolona Intravitreas: Reporte de 22 Casos","volume":"48","author":"Ocampo Dominguez HH","year":"2015","journal-title":"Rev la Soc Colomb Oftalmol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5935\/0004-2749.20150056","article-title":"Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone","volume":"78","author":"Zamora YF","year":"2015","journal-title":"Arq Bras Oftalmol"},{"key":"ref27","series-title":"Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis","first-page":"1080","volume":"Vol. 20","author":"Aggio FB","year":"2006"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/09273948.2017.1307420","article-title":"Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis","volume":"26","author":"Souza CE","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10792-012-9634-1","article-title":"Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: A prospective randomized clinical trial","volume":"33","author":"Baharivand N","year":"2013","journal-title":"Int Ophthalmol"},{"issue":"7","key":"ref30","first-page":"952","article-title":"Facs. Intravitreal Clindamycin for Toxoplasmic retinochoroiditis","volume":"27","author":"Sobrin L","year":"2007","journal-title":"Retin J Retin Vitr Dis"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ophtha.2010.01.028","article-title":"Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months","volume":"117","author":"Lasave AF","year":"2010","journal-title":"Ophthalmology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4160837","DOI":"10.1155\/2018\/4160837","article-title":"Intravitreal clindamycin and dexamethasone combined with systemic oral antitoxoplasma therapy versus intravitreal therapy alone in the management of toxoplasma retinochoroiditis: A retrospective study","volume":"2018","author":"Bor\u2019i A","year":"2018","journal-title":"J Ophthalmol"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/08820538.2013.838278","article-title":"Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: A case series","volume":"30","author":"Kianersi F","year":"2015","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10792-008-9218-2","article-title":"Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis","volume":"28","author":"Ben Yahia S","year":"2008","journal-title":"Int Ophthalmol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2147\/OPTH.S132923","article-title":"Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: A pilot study","volume":"11","author":"Korol AR","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12348-015-0051-2","article-title":"Coexisting choroidal neovascularization and active retinochoroiditis-an uncommon presentation of ocular toxoplasmosis","volume":"5","author":"Hegde S","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"04","key":"ref37","first-page":"8","article-title":"Anti-vascular Endothelial Growth Factor for Choroidal Neovascularization Associated with Toxoplasmosis: A Case Series","volume":"06","author":"Kianersi F","year":"2015","journal-title":"Clin Experiment Ophthalmol"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/PAJO.PAJO_13_19","article-title":"Unusual associations with toxoplasmosis: Report of two cases","volume":"1","author":"Anaya D","year":"2019","journal-title":"Pan-American J Ophthalmol"},{"issue":"2","key":"ref39","first-page":"63","article-title":"Treatment of juxtapapillary toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone injection","volume":"33","author":"Santos EMG","year":"2008","journal-title":"Ophthalmology"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000512286","article-title":"Toxoplasma Retinochoroiditis with Chorioretinal Neovascularization in a Young Patient","volume":"12","author":"Khandwala NS","year":"2021","journal-title":"Case Rep Ophthalmol"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10792-008-9192-8","article-title":"Toxoplasma gondii: An atypical presentation of toxoplasma as optic disc swelling and hemispherical retinal vein occlusion treated with intravitreal clindamycin","volume":"29","author":"Wong R","year":"2009","journal-title":"Int Ophthalmol"},{"issue":"4","key":"ref42","first-page":"1","article-title":"Symptomatic acute toxoplasmosis in returning travelers","volume":"5","author":"Henao-Mart\u00ednez AF","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1006129422690","article-title":"Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine","volume":"22","author":"Martinez CE","year":"1998","journal-title":"Int Ophthalmol"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/IAE.0000000000001001","article-title":"Safety and efficacy of intravitreal dexamethasone implants in the management of macular edema secondary to infectious uveitis","volume":"36","author":"Fonollosa A","year":"2016","journal-title":"Retina"},{"issue":"2","key":"ref45","article-title":"Primary Acquired Toxoplasma Retinochoroiditis: Choroidal Neovascular Membrane as an Early Complication","volume":"11","author":"Mushtaq F","year":"2019","journal-title":"Cureus"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/ICB.0000000000000817","article-title":"Presumed Foveal Bacillary Layer Detachment in a Patient With Toxoplasmosis Chorioretinitis and Pachychoroid Disease","volume":"15","author":"Mehta N","year":"2018","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0974-620X.142598","article-title":"Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor","volume":"7","author":"Mathur G","year":"2014","journal-title":"Oman J Ophthalmol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"100764","DOI":"10.1016\/j.ajoc.2020.100764","article-title":"Optical coherence tomography angiography findings in macular toxoplasma retinochoroiditis: A case report","volume":"19","author":"Perez AL","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.oftal.2019.11.003","article-title":"Management of the neovascular choroidal membrane secondary to ocular toxoplasmosis","volume":"95","author":"Mart\u00edn Garc\u00eda E","year":"2020","journal-title":"Arch la Soc Espa\u00f1ola Oftalmol"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcjo.2013.04.015","article-title":"Intravitreal triamcinolone acetonide in management of ocular toxoplasmosis in an HIV patient: A case report","volume":"48","author":"Bawdekar AC","year":"2013","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/0301-4738.82005","article-title":"Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis","volume":"59","author":"Shah NJ","year":"2011","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5812\/ircmj.15428","article-title":"Intravitreal Clindamycin in the Treatment of Unresponsive Zone One Toxoplasmic Chorioretinitis: A Case Report","volume":"16","author":"Hosseini SM","year":"2014","journal-title":"Iran Red Crescent Med J"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1442-6404.2002.00502.x","article-title":"Hypersensitivity reaction to intravitreal clindamycin therapy","volume":"30","author":"Kim P","year":"2002","journal-title":"Clin Exp Ophthalmol"},{"key":"ref54","article-title":"Foveal Regeneration after Treatment of Acute Foveal Toxoplasmic Chorioretinitis","author":"Abrishami M","year":"2021","journal-title":"Res Sq"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09273948.2019.1657466","article-title":"Driving in Fog without Headlight: Management of a Challenging Case of Presumed Ocular Toxoplasmosis","volume":"29","author":"Dutta Majumder P","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10792-013-9753-3","article-title":"Diffuse infiltrating retinoblastoma coexisting with ocular toxoplasmosis","volume":"34","author":"Ghassemi F","year":"2014","journal-title":"Int Ophthalmol"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0301-4738.73728","article-title":"Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis","volume":"59","author":"ishi P","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"ref58","first-page":"3","article-title":"Atypical toxoplasmic retinochoroiditis","author":"Theodoropoulou S","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"10","key":"ref59","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.4103\/ijo.IJO_364_18","article-title":"Anatomical and functional outcomes of pars plana vitrectomy for inflammatory epiretinal membrane surgery in healed toxoplasmosis infection","volume":"66","author":"Raval V","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"25","key":"ref60","first-page":"115","article-title":"Agujero macular tras toxoplasmosis retiniana.: Presentaci\u00f3n de un caso","author":"S\u00e1nchez Vega C","year":"2014","journal-title":"Arch la Soc Canar Oftalmol"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1869-5760-3-23","article-title":"A typical bilateral Toxoplasma retinochoroiditis in a bone marrow transplant patient with negative serum titers","volume":"3","author":"Hazan A","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"11","key":"ref62","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.clinthera.2008.10.021","article-title":"Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review","volume":"30","author":"Iaccheri B","year":"2008","journal-title":"Clin Ther"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review","volume":"17","author":"Ben-Harari RR","year":"2017","journal-title":"Drugs R D"},{"issue":"7","key":"ref64","first-page":"968","article-title":"Intravitreal clindamycin injection in toxoplasma retinochoroiditis: About 9 cases in the ophthalmology department of the CHU de Bordeaux","volume":"44","author":"Handaye-Dessus A","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.actatropica.2018.04.026","article-title":"Current treatment of ocular toxoplasmosis in immunocompetent patients: A network meta-analysis","volume":"185","author":"Zhang Y","year":"2018","journal-title":"Acta Trop"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"106180","DOI":"10.1016\/j.actatropica.2021.106180","article-title":"Ocular toxoplasmosis, an overview focusing on clinical aspects","volume":"225","author":"Fabiani S","year":"2022","journal-title":"Acta Trop"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1179\/2047773213Y.0000000094","article-title":"Antibiotics for human toxoplasmosis: A systematic review of randomized trials","volume":"107","author":"Rajapakse S","year":"2013","journal-title":"Pathog Glob Health"},{"issue":"1","key":"ref68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","article-title":"The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis","volume":"134","author":"Silveira C","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajo.2019.12.025","article-title":"Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis","volume":"213","author":"Fernandes Felix JP","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jpba.2014.08.023","article-title":"Development of a method to quantify clindamycin in vitreous humor of rabbits\u2019 eyes by UPLC-MS\/MS: Application to a comparative pharmacokinetic study and in vivo ocular biocompatibility evaluation","volume":"102","author":"Fernandes-Cunha GM","year":"2015","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10856-015-5621-1","article-title":"Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants","volume":"27","author":"Fernandes-Cunha GM","year":"2016","journal-title":"J Mater Sci Mater Med"},{"issue":"5","key":"ref72","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11095-017-2118-2","article-title":"Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants","volume":"34","author":"Fernandes-Cunha GM","year":"2017","journal-title":"Pharm Res"},{"issue":"9","key":"ref73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/jop.2015.0059","article-title":"Current Therapy of Acquired Ocular Toxoplasmosis: A Review","volume":"31","author":"Cerqueira Lima GS","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000449169","article-title":"Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis","volume":"57","author":"Ozgonul C","year":"2016","journal-title":"Ophthalmic Res"},{"issue":"5","key":"ref75","article-title":"Antibiotics versus no treatment for toxoplasma retinochoroiditis","volume":"2016","author":"Pradhan E","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref76","first-page":"1","article-title":"Treatment of Toxoplasmosis : Historical Perspective , Animal","volume":"31","author":"Dunay IR","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01758-7","article-title":"Safety and efficacy of different antibiotic regimens in patients with ocular toxoplasmosis: systematic review and meta-analysis","volume":"10","author":"Feliciano-Alfonso JE","year":"2021","journal-title":"Syst Rev"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08820530500231961","article-title":"Toxoplasmosis","volume":"20","author":"Bonfioli AA","year":"2005","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","article-title":"A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis","volume":"134","author":"Bosch-Driessen LH","year":"2002","journal-title":"Am J Ophthalmol"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0037-86822023000100319&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T12:40:43Z","timestamp":1684759243000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822023000100319&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":79,"alternative-id":["S0037-86822023000100319"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0552-2022","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e0552-2022"}}